Vesilute
Also known as: ED Dipeptide, Glu-Asp, L-Glutamyl-L-Aspartic Acid
Key Facts: Vesilute
- Category
- Anti-Aging
- FDA Status
- Not FDA Approved
- Clinical Status
- Preclinical - Limited human studies, available as supplement in some regions
- Administration
- Oral capsules
- Typical Dose
- 1-2 capsules (10-20 mg) daily
- Frequency
- 1-2x daily, before meals
- Duration
- 30-day courses, repeat after 4-6 months
Mechanism of Action
Vesilute is a dipeptide bioregulator that targets urogenital tissue. It is believed to normalize cellular function by reducing peptide deficiency and restoring protein synthesis inside cells. Research suggests it may enhance microcirculation within the prostate and support bladder function through epigenetic regulation of gene expression.
Research Summary
Part of Professor Khavinson's bioregulator research at the Saint Petersburg Institute of Bioregulation and Gerontology. Studies investigate potential role in supporting urinary tract and prostate health. Research suggests it may alleviate symptoms linked to bladder dysfunction and reduce prostate issues by improving local circulation. Limited published peer-reviewed data compared to other Khavinson peptides.
Dosing Information
Typical Dosingⓘ
Community experience
1-2 capsules (10-20 mg) daily
10-20 mg per day
1-2x daily, before meals
Khavinson bioregulator for urogenital support. Often used in 30-day cycles. May be combined with Prostamax for prostate support in men. Limited Western research available.
Research Dosingⓘ
Scientific studies
Khavinson bioregulator dosing
Doses from Studies
Duration
30-day courses, repeat after 4-6 months
Administration
Oral capsules
Timing & Administration
Best Time to Take
Morning, before meals
1-2 times daily
Food Recommendation
With or without food
Why This Timing?
Bioregulator peptides typically taken morning on empty stomach for optimal absorption.
Possible Side Effects
Not everyone experiences these effects. Individual responses vary based on dosage, duration, and personal factors.
- ●Generally well-tolerated
- ●Limited safety data in Western literature
- ●Individual intolerance possible
- ●Unknown long-term effects
References
Research This Peptide Further
Frequently Asked Questions
What does Vesilute do?
A synthetic dipeptide (Glu-Asp) bioregulator from the Khavinson peptide family, studied for urinary tract and prostate support. Research suggests it may help with bladder function and prostate microcirculation. Part of the tissue-specific bioregulatory compounds developed over 40+ years of research.
How does Vesilute work?
Vesilute is a dipeptide bioregulator that targets urogenital tissue. It is believed to normalize cellular function by reducing peptide deficiency and restoring protein synthesis inside cells. Research suggests it may enhance microcirculation within the prostate and support bladder function through epigenetic regulation of gene expression.
Is Vesilute FDA approved?
No, Vesilute is not currently FDA approved. Current status: Preclinical - Limited human studies, available as supplement in some regions
What are the side effects of Vesilute?
Reported side effects include: Generally well-tolerated, Limited safety data in Western literature, Individual intolerance possible, Unknown long-term effects. Individual responses vary based on dosage, duration, and personal health factors.
What is the typical dose of Vesilute?
Community-reported common dose: 1-2 capsules (10-20 mg) daily (1-2x daily, before meals). Range: 10-20 mg per day. Administration: Oral capsules. Community-reported doses. Not FDA approved. Consult healthcare provider.
Related Peptides
Peptides commonly compared with Vesilute or used in similar applications.
Humanin
PreclinicalA mitochondria-derived peptide discovered for its neuroprotective effects against Alzheimer's-related toxicity. Being studied for aging and metabolic benefits.
Anti-AgingFOXO4-DRI
PreclinicalA senolytic peptide designed to selectively eliminate senescent 'zombie' cells by disrupting the FOXO4-p53 interaction. Shows promise for restoring tissue function in aging, including kidney health restoration.
Anti-AgingGlutathione
Clinical TrialsThe body's master antioxidant - a tripeptide composed of glutamate, cysteine, and glycine. Found in every cell at concentrations similar to glucose (5mM). Essential for detoxification, immune function, and cellular protection against oxidative stress.
Anti-AgingDSIP
Clinical TrialsA neuropeptide that promotes deep delta wave sleep. First isolated from rabbit brains in 1977. Used for sleep optimization and stress reduction.
Anti-AgingNAD+ Precursors
Clinical TrialsWhile not peptides, NAD+ precursors are frequently discussed alongside peptides in longevity circles. They boost cellular NAD+ levels, supporting energy metabolism and sirtuin activity.
Anti-AgingSS-31
FDAA mitochondria-targeted peptide that improves cellular energy production. FDA approved for Barth syndrome (September 2025) as FORZINITY, the first approved mitochondria-targeted therapeutic.
Anti-AgingWant updates on Vesilute research?
Subscribe to get notified when we add new research findings, protocol updates, and related peptide information.